<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Soft tissue infections following water exposure
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Soft tissue infections following water exposure
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Soft tissue infections following water exposure
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Larry M Baddour, MD, FIDSA, FAHA
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Daniel J Sexton, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sandra Nelson, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Keri K Hall, MD, MS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Oct 13, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Soft tissue infection due to a broad array of organisms can occur in patients with traumatic injury associated with water exposure [
         <a href="#rid1">
          1,2
         </a>
         ].
        </p>
        <p>
         The epidemiology, microbiology, clinical manifestations, diagnosis, and treatment of soft tissue infections following water exposure are reviewed here.
        </p>
        <p>
         Issues related to jellyfish stings and marine envenomations are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2752.html" rel="external">
          "Jellyfish stings"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6591.html" rel="external">
          "Marine envenomations from corals, sea urchins, fish, or stingrays"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2457205521">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The risk of soft tissue infection due to traumatic injury with water exposure may be considered in the following hierarchy (from highest to lowest risk)  (
         <a class="graphic graphic_table graphicRef75469" href="/z/d/graphic/75469.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid1">
          1-3
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fresh water (ponds, small lakes)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Flowing fresh water (rivers, large lakes)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Brackish water (water that is saltier than fresh water but less salty than sea water, found where bodies of sea water and fresh water meet)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sea water
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Well-regulated treated water (swimming pools, hot tubs)
        </p>
        <p>
        </p>
        <p>
         In addition to water, other relevant exposures may include mud, sand, debris, or sewage.
        </p>
        <p>
         Injuries associated with water exposure include lacerations (due to inanimate objects in water), puncture wounds due to fish hooks or fish spines, and bites from aquatic animals [
         <a href="#rid4">
          4-7
         </a>
         ]. In addition, water exposure in patients with pre-existing wounds can result in infection.
        </p>
        <p>
         Individuals at risk for soft tissue infection following water exposure include [
         <a href="#rid8">
          8-13
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Recreational swimmers, fisherman, boaters, fishmongers
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Flooding victims and rescue workers
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         People undergoing leech therapy
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with underlying liver disease and immunosuppression
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         People who inject drugs [
         <a href="#rid14">
          14-16
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2044943829">
         <span class="h1">
          MICROBIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Some of the organisms that can cause soft tissue infections following water exposure include  (
         <a class="graphic graphic_table graphicRef75469" href="/z/d/graphic/75469.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid1">
          1,2,17-19
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Aeromonas
         </em>
         spp (see
         <a class="medical medical_review" href="/z/d/html/3138.html" rel="external">
          "Aeromonas infections"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Burkholderia pseudomallei
         </em>
         (see
         <a class="medical medical_review" href="/z/d/html/3146.html" rel="external">
          "Melioidosis: Epidemiology, clinical manifestations, and diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Chromobacterium violaceum
         </em>
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Edwardsiella tarda
         </em>
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Erysipelothrix rhusiopathiae
         </em>
         (see
         <a class="medical medical_review" href="/z/d/html/5537.html" rel="external">
          "Erysipelothrix infection"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Mycobacterium fortuitum
         </em>
         (see
         <a class="medical medical_review" href="/z/d/html/5347.html" rel="external">
          "Rapidly growing mycobacterial infections: Mycobacteria abscessus, chelonae, and fortuitum"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Mycobacterium marinum
         </em>
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Plesiomonas
         </em>
         spp (see
         <a class="medical medical_review" href="/z/d/html/3132.html" rel="external">
          "Plesiomonas shigelloides infections"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Pseudomonas aeruginosa
         </em>
         (see
         <a class="medical medical_review" href="/z/d/html/7643.html" rel="external">
          "Pseudomonas aeruginosa skin and soft tissue infections"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Shewanella
         </em>
         spp
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Streptococcus iniae
         </em>
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Vibrio
         </em>
         spp (see
         <a class="medical medical_review" href="/z/d/html/3128.html" rel="external">
          "Vibrio vulnificus infection"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3127.html" rel="external">
          "Vibrio parahaemolyticus infections"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16535.html" rel="external">
          "Minor Vibrio and Vibrio-like species associated with human disease"
         </a>
         )
        </p>
        <p>
        </p>
        <p>
         Note that this listing of organisms is not all-inclusive; thus, it is important to obtain specimens (blood, drainage, tissue) for microbiologic examination when possible. In addition, soft tissue infection following water exposure can be caused by organisms unrelated to water exposure (such as beta-hemolytic streptococci and
         <em>
          Staphylococcus aureus
         </em>
         ). Polymicrobial infection may occur [
         <a href="#rid20">
          20,21
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/110529.html" rel="external">
          "Cellulitis and skin abscess: Epidemiology, microbiology, clinical manifestations, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7662.html" rel="external">
          "Necrotizing soft tissue infections"
         </a>
         .)
        </p>
        <p>
         The microbiology depends on the type of water exposure as well as individual patient factors  (
         <a class="graphic graphic_table graphicRef75469" href="/z/d/graphic/75469.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h1">
          CLINICAL EVALUATION
         </span>
        </p>
        <p class="headingAnchor" id="H794943732">
         <span class="h2">
          History and physical examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients presenting for initial evaluation and management of a wound associated with water exposure, a thorough exposure history should be obtained, including occupational and home exposures, hobbies, and recent travel history.
        </p>
        <p>
         Soft tissue infection following water exposure may be superficial (eg, cellulitis, with or without abscess) or deep (abscess, septic arthritis, osteomyelitis, tenosynovitis, or necrotizing soft tissue infection) [
         <a href="#rid11">
          11
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Clinical manifestations of cellulitis include fever, tenderness, erythema, swelling, and warmth; purulent drainage and/or lymphangitis may be present. An associated superficial abscess may present as a tender, erythematous, fluctuant nodule or lump.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In addition to the above manifestations, clues for deep infection include persistent or progressive pain several days following the initial injury, pain with passive movement, pain out of proportion to exam findings, crepitus, joint swelling, systemic illness (fever, hemodynamic instability), and persistent signs of infection despite initial wound care and antibiotic administration.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The level of suspicion for deep infection should be increased for patients with immunosuppression (including diabetes) or neuropathy; these patients often present later in their course with increased risk of serious infection and limited pain on clinical exam.
        </p>
        <p>
        </p>
        <p>
         The clinical manifestations, microbiology, epidemiology, and incubation period for various infections following water exposure are summarized in the table  (
         <a class="graphic graphic_table graphicRef75469" href="/z/d/graphic/75469.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
         The range of clinical manifestations of skin and soft tissue infections following water exposure is illustrated by the following examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Vibrio vulnificus
         </em>
         is associated with rapidly progressive soft tissue infection (incubation period three to seven days). Relevant epidemiologic exposures include raw oyster ingestion and/or exposure of puncture wounds to salt water, especially in males with chronic liver disease. When ocean waters are warmer than usual, rates of infection due to
         <em>
          V. vulnificus
         </em>
         may increase; for example, in the summer of 2023, the United States Centers for Disease Control and Prevention (CDC) issued a warning about increasing infections along the East Coast and Gulf of Mexico, associated with warmer than normal ocean temperatures [
         <a href="#rid22">
          22
         </a>
         ]. Clinical manifestations may include cellulitis, hemorrhagic bullae, ulcers, necrotizing infection with compartment syndrome, ecthyma gangrenosum, and septicemia  (
         <a class="graphic graphic_picture graphicRef63423" href="/z/d/graphic/63423.html" rel="external">
          picture 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/3128.html" rel="external">
          "Vibrio vulnificus infection"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7662.html" rel="external">
          "Necrotizing soft tissue infections"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          M. marinum
         </em>
         is associated with indolent infection (mean incubation period 21 days). Relevant epidemiologic exposures include cleaning salt water aquariums, punctures from fish hooks, or seafood preparation involving crustaceans. Lesions usually appear as papules or nodules on an extremity (especially on the elbows, knees, and dorsum of feet and hands); subsequently, they progress to shallow ulceration and scar formation  (
         <a class="graphic graphic_picture graphicRef81640" href="/z/d/graphic/81640.html" rel="external">
          picture 2
         </a>
         ). Most lesions are solitary; occasionally "ascending" lesions develop with "sporotrichoid spread" (ie, resembling sporotrichosis; also called nodular lymphangitis). In one series including 31 patients with
         <em>
          M. marinum
         </em>
         infection, the upper extremity was affected in 90 percent of cases; nodular lymphangitis occurred in 81 percent of cases [
         <a href="#rid23">
          23
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2457.html" rel="external">
          "Clinical features and diagnosis of sporotrichosis", section on 'Nodular lymphangitis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5344.html" rel="external">
          "Epidemiology of nontuberculous mycobacterial infections"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7643.html" rel="external">
          "Pseudomonas aeruginosa skin and soft tissue infections", section on 'Hot tub-associated eruptions'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2741.html" rel="external">
          "Lymphangitis", section on 'Nodular lymphangitis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Clinical manifestations of necrotizing soft tissue infection (erythema, edema, warmth, and signs of systemic illness [fever, hemodynamic instability] in association with crepitus, rapid progression of clinical manifestations, and/or severe pain [out of proportion to skin findings in some cases]) are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/7662.html" rel="external">
          "Necrotizing soft tissue infections"
         </a>
         .)
        </p>
        <p>
         The likelihood of wound infection should be determined based upon physical findings.
        </p>
        <p class="headingAnchor" id="H191886880">
         <span class="h2">
          Laboratory testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients with clinically uninfected wounds, routine laboratory studies are not indicated. Similarly, wound cultures are not indicated; such results do not correlate with subsequent infection.
        </p>
        <p>
         For patients with clinically infected wounds, laboratory studies (complete blood count and serum inflammatory markers such as erythrocyte sedimentation rate, C-reactive protein) are reasonable. In addition, wound cultures (aerobic and anaerobic) should be obtained from infected wounds to establish the microbiology of the infection and to guide antibiotic therapy.
        </p>
        <p>
         If consideration of
         <em>
          M. marinum
         </em>
         is warranted, the microbiology laboratory should be notified so that acid-fast staining and mycobacterial culture can be performed; growth of
         <em>
          M. marinum
         </em>
         is generally restricted to lower temperatures. Other diagnostic tools that may be useful to establish a diagnosis of
         <em>
          M. marinum
         </em>
         infection include histopathology, immunohistochemistry (IC), and polymerase chain reaction (PCR) from full-thickness skin biopsy; IC and PCR may not be readily available in most clinical laboratories [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
         Blood cultures should be obtained in the setting of fever or hemodynamic instability, as well as in patients at increased risk for systemic infection (including underlying hepatic disease, cancer, or immunosuppression).
        </p>
        <p class="headingAnchor" id="H3068602101">
         <span class="h2">
          Imaging
         </span>
         <span class="headingEndMark">
          —
         </span>
         Imaging is not necessary for most clinically uninfected, superficial wounds. Deep wounds, including those near joints warrant diagnostic imaging (plain radiography) to exclude retained foreign body [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2671667099">
         <span class="h1">
          MANAGEMENT
         </span>
        </p>
        <p class="headingAnchor" id="H824628502">
         <span class="h2">
          Uninfected wound
         </span>
         <span class="headingEndMark">
          —
         </span>
         Management of a wound following water exposure includes wound care and evaluation regarding need for antibiotic prophylaxis and/or tetanus prophylaxis.
        </p>
        <p class="headingAnchor" id="H831258294">
         <span class="h3">
          Wound management
         </span>
         <span class="headingEndMark">
          —
         </span>
         Wounds associated with water exposure should be irrigated copiously with sterile
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         . Crushed or devitalized tissues should be debrided and foreign bodies should be removed if present.
        </p>
        <p class="headingAnchor" id="H3296855035">
         <span class="h4">
          Closure
         </span>
         <span class="headingEndMark">
          —
         </span>
         The optimal approach to closure of uninfected wounds associated with water exposure is uncertain and depends in part on the nature of the exposure. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
         Indications for surgical consultation are summarized below. (See
         <a class="local">
          'Surgical consultation'
         </a>
         below.)
        </p>
        <p>
         In general, closure of wounds associated with exposure to a treated swimming pool or hot tub is reasonable. In addition, closure of large wounds or wounds in cosmetically important areas associated with exposure to sea water, brackish water, or relatively clean fresh water (such as rivers or large lakes) may be reasonable.
        </p>
        <p>
         For patients with wounds in cosmetically important areas associated with exposure to ponds or small lakes who do not undergo surgical debridement, it may be reasonable to administer prophylactic antibiotics followed by return for delayed primary closure after two to three days if no signs of infection are present.
        </p>
        <p>
         Follow-up of patients with closed traumatic wounds is important, particularly in the first several days following closure. Such follow-up may be done via outpatient visits and/or via serial photographs sent by patients (depending upon the severity of the injury and available resources).
        </p>
        <p class="headingAnchor" id="H3157247644">
         <span class="h4">
          Surgical consultation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Surgical consultation is warranted in the following circumstances:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Substantial wounds associated with exposure to a pond or small lake
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Complex facial lacerations
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Deep wounds that penetrate bone, tendons, joints, or other major structures
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Wounds associated with neurovascular compromise
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H113183489">
         <span class="h3">
          Antibiotic prophylaxis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The optimal approach to post-exposure prophylactic antibiotic therapy in patients with an open wound associated with water exposure (in the absence of established infection) is uncertain; there are no clinical trial data evaluating whether prophylactic therapy is beneficial [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
         In general, post-exposure prophylactic antibiotic therapy is reasonable in the following circumstances:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Deep puncture wound or laceration (beyond the dermis)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Wounds requiring surgical repair
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Wounds undergoing primary closure associated with any water exposure apart from well-regulated treated swimming pools or hot tubs (see
         <a class="local">
          'Epidemiology'
         </a>
         above)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Wound with associated crush injury
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Wound in area of underlying vascular or lymphatic compromise
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Wound on the hands, feet, face, or genital area
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Wound near a bone or joint (particularly a prosthetic joint)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Wounds in immunocompromised patients or those with diabetes or chronic liver disease
        </p>
        <p>
        </p>
        <p>
         The choice of prophylactic antibiotic therapy should be based on the epidemiology of the exposure and patient factors. (See
         <a class="local">
          'Empiric therapy'
         </a>
         below.)
        </p>
        <p>
         The duration of prophylactic oral antibiotics is three to five days, with close follow-up. Signs of infection on follow-up examination should prompt further evaluation (with radiographic imaging and/or surgical consultation, if needed), an extension of the antibiotic course, and/or a switch to intravenous therapy.
        </p>
        <p class="headingAnchor" id="H4009615180">
         <span class="h2">
          Infected wound
         </span>
         <span class="headingEndMark">
          —
         </span>
         Management of patients with soft tissue infection following water exposure includes wound debridement (with collection of microbiology specimens) and administration of empiric antibiotic therapy. In addition, patients should be evaluated regarding need for tetanus prophylaxis. (See
         <a class="local">
          'Preventing tetanus'
         </a>
         below.)
        </p>
        <p>
         Management of patients with suspected necrotizing soft tissue infection is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/7662.html" rel="external">
          "Necrotizing soft tissue infections"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/108059.html" rel="external">
          "Surgical management of necrotizing soft tissue infections"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H975266553">
         <span class="h3">
          Wound management
         </span>
         <span class="headingEndMark">
          —
         </span>
         Wounds associated with water exposure should be irrigated copiously with sterile
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         . Crushed or devitalized tissues should be debrided and foreign bodies should be removed if present. Specimens (eg, lesion aspirate or biopsy) should be sent for Gram stain and culture (aerobic and anaerobic) as well as acid-fast stain and mycobacterial culture.
        </p>
        <p>
         Acute infected wounds associated with water exposure should be left open with approximation of wound edges to facilitate closure by secondary intention following initial debridement. Delayed primary closure may be reasonable for facial wounds, large lacerations, and disfiguring wounds; factors to consider in this decision are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/15912.html" rel="external">
          "Basic principles of wound management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13875.html" rel="external">
          "Assessment and management of facial lacerations"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2581863493">
         <span class="h3">
          Antibiotic therapy
         </span>
        </p>
        <p class="headingAnchor" id="H2583633867">
         <span class="h4">
          Route of therapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Inpatient administration of intravenous antibiotics is warranted for patients with systemic symptoms (eg, fever, chills, rigors) and/or leukocytosis. Similarly, intravenous antibiotic therapy is warranted for patients with underlying hepatic disease, cancer, or immunosuppression; these groups are at increased risk for complications including bacteremia, sepsis and, death.
        </p>
        <p>
         The route of antibiotic administration may be switched from parenteral to oral once fever and soft tissue findings have begun to resolve (often three to five days).
        </p>
        <p>
         In the absence of the above factors, outpatient administration of oral antibiotic therapy is reasonable, with close follow-up within 24 to 48 hours.
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h4">
          Empiric therapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Empiric antibiotic regimens are based on the most likely organisms to cause infection, in vitro susceptibility studies, and treatment case series [
         <a href="#rid1">
          1-3
         </a>
         ].
        </p>
        <p>
         For patients with soft tissue infection following water exposure, we use the following antibiotics for initial empiric therapy:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A first-generation cephalosporin (
         <a class="drug drug_general" data-topicid="9231" href="/z/d/drug information/9231.html" rel="external">
          cephalexin
         </a>
         500 mg orally four times daily or
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         1 g intravenously every eight hours); for patients with immediate hypersensitivity reactions to cephalosporins,
         <a class="drug drug_general" data-topicid="10283" href="/z/d/drug information/10283.html" rel="external">
          linezolid
         </a>
         (600 mg orally or intravenously every 12 hours) is an alternative agent.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <strong>
          PLUS
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A fluoroquinolone such as
         <a class="drug drug_general" data-topicid="9554" href="/z/d/drug information/9554.html" rel="external">
          levofloxacin
         </a>
         (750 mg once daily)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <strong>
          PLUS
         </strong>
         (if epidemiologic risk is present)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Seawater exposure:
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         (100 mg twice daily) for coverage of
         <em>
          Vibrio
         </em>
         species
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Soil-contaminated wound or exposure to sewage-contaminated water:
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         (500 mg four times daily) for anaerobic coverage
        </p>
        <p>
        </p>
        <p>
         Issues related to empiric treatment of patients with suspected necrotizing soft tissue infection are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/7662.html" rel="external">
          "Necrotizing soft tissue infections"
         </a>
         .)
        </p>
        <p>
         Empiric antibiotic therapy need not include coverage for mycobacterial infection unless acid-fast staining is positive. In such cases, directed therapy should be administered as described below. (See
         <a class="local">
          'Mycobacterial infection'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h4">
          Directed therapy
         </span>
        </p>
        <p class="headingAnchor" id="H1493142591">
         <span class="h5">
          Bacterial infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Empiric antibiotic therapy should be tailored to microbiology data when available. General information regarding antimicrobial susceptibility for organisms associated with water exposure is presented in the table  (
         <a class="graphic graphic_table graphicRef75469" href="/z/d/graphic/75469.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
         Treatment of infection due to
         <em>
          Aeromonas
         </em>
         spp,
         <em>
          B. pseudomallei, E. rhusiopathiae, Plesiomonas
         </em>
         spp,
         <em>
          P. aeruginosa, S. aureus, Streptococcus pyogenes,
         </em>
         and
         <em>
          Vibrio
         </em>
         spp is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/3138.html" rel="external">
          "Aeromonas infections"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3136.html" rel="external">
          "Melioidosis: Treatment and prevention"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5537.html" rel="external">
          "Erysipelothrix infection"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3132.html" rel="external">
          "Plesiomonas shigelloides infections"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7643.html" rel="external">
          "Pseudomonas aeruginosa skin and soft tissue infections"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/110530.html" rel="external">
          "Acute cellulitis and erysipelas in adults: Treatment"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3128.html" rel="external">
          "Vibrio vulnificus infection"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3127.html" rel="external">
          "Vibrio parahaemolyticus infections"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16535.html" rel="external">
          "Minor Vibrio and Vibrio-like species associated with human disease"
         </a>
         .)
        </p>
        <p>
         Issues related to treatment of patients with suspected necrotizing soft tissue infection are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/7662.html" rel="external">
          "Necrotizing soft tissue infections"
         </a>
         .)
        </p>
        <p>
         For most soft tissue infections due to bacteria associated with water exposure, a reasonable duration of therapy is 10 to 14 days. If local signs of infection persist after two weeks of treatment, we continue antibiotic therapy until signs of infection resolve.
        </p>
        <p class="headingAnchor" id="H3277577276">
         <span class="h5">
          Mycobacterial infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with infection due to nontuberculous mycobacteria (
         <em>
          M. fortuitum
         </em>
         or
         <em>
          M. marinum
         </em>
         ) generally warrant months of therapy. Issues related to treatment of
         <em>
          M. fortuitum
         </em>
         infection are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5347.html" rel="external">
          "Rapidly growing mycobacterial infections: Mycobacteria abscessus, chelonae, and fortuitum"
         </a>
         .)
        </p>
        <p>
         Treatment of
         <em>
          M. marinum
         </em>
         infection is based on in vitro susceptibility testing and case reports; the optimal approach is uncertain [
         <a href="#rid26">
          26,27
         </a>
         ].
         <em>
          M. marinum
         </em>
         isolates are usually susceptible to
         <a class="drug drug_general" data-topicid="9864" href="/z/d/drug information/9864.html" rel="external">
          rifampin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9430" href="/z/d/drug information/9430.html" rel="external">
          ethambutol
         </a>
         ,
         <a class="drug drug_general" data-topicid="9273" href="/z/d/drug information/9273.html" rel="external">
          clarithromycin
         </a>
         , sulfonamides, and
         <a class="drug drug_general" data-topicid="9785" href="/z/d/drug information/9785.html" rel="external">
          trimethoprim-sulfamethoxazole
         </a>
         ; susceptible or intermediately susceptible to
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         and
         <a class="drug drug_general" data-topicid="9653" href="/z/d/drug information/9653.html" rel="external">
          minocycline
         </a>
         ; intermediately susceptible to
         <a class="drug drug_general" data-topicid="10238" href="/z/d/drug information/10238.html" rel="external">
          streptomycin
         </a>
         ; and resistant to
         <a class="drug drug_general" data-topicid="8577" href="/z/d/drug information/8577.html" rel="external">
          isoniazid
         </a>
         and
         <a class="drug drug_general" data-topicid="9836" href="/z/d/drug information/9836.html" rel="external">
          pyrazinamide
         </a>
         .
        </p>
        <p>
         For treatment of superficial papules due to
         <em>
          M. marinum
         </em>
         , monotherapy with one of the following regimens is reasonable:
         <a class="drug drug_general" data-topicid="9273" href="/z/d/drug information/9273.html" rel="external">
          clarithromycin
         </a>
         (500 mg orally twice daily),
         <a class="drug drug_general" data-topicid="9653" href="/z/d/drug information/9653.html" rel="external">
          minocycline
         </a>
         (100 mg orally twice daily),
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         (100 mg orally twice daily), or
         <a class="drug drug_general" data-topicid="9785" href="/z/d/drug information/9785.html" rel="external">
          trimethoprim-sulfamethoxazole
         </a>
         (one double-strength tablet orally twice daily) [
         <a href="#rid23">
          23,28-30
         </a>
         ].
        </p>
        <p>
         For treatment of deeper or more extensive infection due to
         <em>
          M. marinum
         </em>
         , we favor treatment with two active agents. A reasonable regimen consists of
         <a class="drug drug_general" data-topicid="9273" href="/z/d/drug information/9273.html" rel="external">
          clarithromycin
         </a>
         (500 mg orally twice daily) combined with either
         <a class="drug drug_general" data-topicid="9430" href="/z/d/drug information/9430.html" rel="external">
          ethambutol
         </a>
         (15 mg/kg orally once daily) or
         <a class="drug drug_general" data-topicid="9864" href="/z/d/drug information/9864.html" rel="external">
          rifampin
         </a>
         (600 mg orally once daily).
        </p>
        <p>
         We continue treatment of
         <em>
          M. marinum
         </em>
         infection for one to two months following resolution of symptoms (total duration is typically three to four months) [
         <a href="#rid26">
          26,31
         </a>
         ]. The rate of clinical response is variable; at least four to six weeks of therapy should be administered before inadequate response should be suspected.
        </p>
        <p>
         For disease involving the closed spaces of the hand or disease that responds poorly to drug therapy, surgical debridement may be warranted [
         <a href="#rid32">
          32,33
         </a>
         ].
        </p>
        <p>
         In one series including 63 patients with
         <em>
          M. marinum
         </em>
         infection, the median duration of antibiotics was 14 weeks (range 1 to 25 months) [
         <a href="#rid34">
          34
         </a>
         ]. Cure was achieved in 87 percent of cases; treatment failure was associated with involvement of deeper structures (but not the antibiotic regimen). A combination regimen was administered in 63 percent of cases (most commonly
         <a class="drug drug_general" data-topicid="9273" href="/z/d/drug information/9273.html" rel="external">
          clarithromycin
         </a>
         plus
         <a class="drug drug_general" data-topicid="9864" href="/z/d/drug information/9864.html" rel="external">
          rifampin
         </a>
         ); among patients treated with monotherapy, the most common regimen was
         <a class="drug drug_general" data-topicid="9653" href="/z/d/drug information/9653.html" rel="external">
          minocycline
         </a>
         or
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         .
        </p>
        <p class="headingAnchor" id="H2025137703">
         <span class="h1">
          PREVENTING TETANUS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The patient's tetanus immunization status should be reviewed [
         <a href="#rid35">
          35
         </a>
         ]. Tetanus toxoid, diphtheria-tetanus-acellular pertussis, booster tetanus toxoid-reduced diphtheria toxoid-acellular pertussis, or tetanus-diphtheria toxoids adsorbed should be administered as indicated  (
         <a class="graphic graphic_table graphicRef61087" href="/z/d/graphic/61087.html" rel="external">
          table 2
         </a>
         ). The need for
         <a class="drug drug_general" data-topicid="9983" href="/z/d/drug information/9983.html" rel="external">
          tetanus immune globulin
         </a>
         should also be assessed  (
         <a class="graphic graphic_table graphicRef61087" href="/z/d/graphic/61087.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/5525.html" rel="external">
          "Tetanus"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H788242742">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/110086.html" rel="external">
          "Society guideline links: Skin and soft tissue infections"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk factors
         </strong>
         – The risk of soft tissue infection associated with water exposure may be considered in the following hierarchy (from highest to lowest risk) (see
         <a class="local">
          'Epidemiology'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Fresh water (ponds, small lakes)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Flowing fresh water (rivers, large lakes)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Brackish water (water that is saltier than fresh water but less salty than sea water, found where bodies of sea water and fresh water meet)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Sea water
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Well-regulated treated swimming pools, hot tubs
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In addition to water, other relevant exposures may include mud, sand, or sewage.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Patients with underlying liver disease and immunosuppression are at increased risk for soft tissue infection associated with water exposure as well as systemic infection. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Types of injuries
         </strong>
         – Injuries associated with water exposure include lacerations (due to inanimate objects in water), puncture wounds due to fishhooks or spines, and bites from aquatic animals. (See
         <a class="local">
          'History and physical examination'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Types of infection
         </strong>
         – These include cellulitis, abscess formation, necrotizing soft tissue processes (eg, fasciitis and myositis), and bone and joint infection. The microbiology, epidemiology, incubation period, and clinical manifestations are summarized in the table  (
         <a class="graphic graphic_table graphicRef75469" href="/z/d/graphic/75469.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Clinical evaluation'
         </a>
         above and
         <a class="local">
          'Microbiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management of uninfected wounds
         </strong>
         – Components of management of uninfected wounds include local wound care and administration of antibiotic prophylaxis and tetanus prophylaxis, as needed  (
         <a class="graphic graphic_table graphicRef61087" href="/z/d/graphic/61087.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="local">
          'Uninfected wound'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Wound management
         </strong>
         – The optimal approach for closure of uninfected wounds associated with water exposure depends on the nature of the exposure, as discussed above (see
         <a class="local">
          'Closure'
         </a>
         above). Indications for surgical consultation are summarized above. (See
         <a class="local">
          'Surgical consultation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Post-exposure antibiotic prophylaxis
         </strong>
         – We suggest administering prophylactic antibiotic therapy for patients with wounds associated with water exposure in the following circumstances (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ) (see
         <a class="local">
          'Antibiotic prophylaxis'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Deep puncture wound or laceration (beyond the dermis)
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Wounds requiring surgical repair
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Wounds undergoing primary closure associated with any water exposure apart from well-regulated treated swimming pools or hot tubs (see
         <a class="local">
          'Epidemiology'
         </a>
         above)
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Wound with associated crush injury
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Wound in area of underlying vascular or lymphatic compromise
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Wound on the hands, feet, face, or genital area
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Wound in close proximity to a bone or joint (particularly a prosthetic joint)
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Wounds in immunocompromised patients or those with diabetes or chronic liver disease
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management of infection wounds
         </strong>
         – Components of management for infected wounds include surgical consultation for selected patients as described above, debridement of infected tissue, obtaining wound cultures (and blood cultures in patients with signs of systemic infection or immunocompromise), administration of antibiotic therapy, and providing tetanus prophylaxis as indicated. (See
         <a class="local">
          'Infected wound'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preferred empiric antibiotic regimen
         </strong>
         – The following antibiotic regimen may be administered prophylactically for prevention of soft tissue infection following water exposure or empirically for treatment of established soft tissue infection (see
         <a class="local">
          'Antibiotic prophylaxis'
         </a>
         above and
         <a class="local">
          'Empiric therapy'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A first-generation cephalosporin (eg,
         <a class="drug drug_general" data-topicid="9231" href="/z/d/drug information/9231.html" rel="external">
          cephalexin
         </a>
         500 mg orally four times daily or
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         1 g intravenously every eight hours)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <strong>
          PLUS
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_general" data-topicid="9554" href="/z/d/drug information/9554.html" rel="external">
          Levofloxacin
         </a>
         (750 mg orally or intravenously once daily)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <strong>
          PLUS
         </strong>
         (if epidemiologic risk is present)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Seawater exposure:
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         (100 mg orally or intravenously every 12 hours) for coverage of
         <em>
          Vibrio
         </em>
         species
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Soil-contaminated wound or exposure to sewage-contaminated water:
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         (500 mg orally or intravenously every six hours) for anaerobic coverage
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Tailoring antibiotics
         </strong>
         – General information regarding antimicrobial susceptibility for organisms associated with water exposure is presented in the table  (
         <a class="graphic graphic_table graphicRef75469" href="/z/d/graphic/75469.html" rel="external">
          table 1
         </a>
         ). For most soft tissue infections due to bacteria associated with water exposure, a reasonable duration of therapy is 10 to 14 days. (See
         <a class="local">
          'Bacterial infection'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment of
         </strong>
         <strong>
          <em>
           Mycobacterium marinum
          </em>
         </strong>
         <strong>
          infection
         </strong>
         – Optimal treatment of
         <em>
          M. marinum
         </em>
         infection is uncertain. For treatment of superficial papules due to
         <em>
          M. marinum
         </em>
         , we suggest monotherapy (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ); reasonable regimens include
         <a class="drug drug_general" data-topicid="9273" href="/z/d/drug information/9273.html" rel="external">
          clarithromycin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9653" href="/z/d/drug information/9653.html" rel="external">
          minocycline
         </a>
         ,
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         , or
         <a class="drug drug_general" data-topicid="9785" href="/z/d/drug information/9785.html" rel="external">
          trimethoprim-sulfamethoxazole
         </a>
         . For treatment of deeper or more extensive infection due to
         <em>
          M. marinum
         </em>
         , we suggest combination therapy with two active agents (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ); a reasonable regimen consists of clarithromycin combined with
         <a class="drug drug_general" data-topicid="9430" href="/z/d/drug information/9430.html" rel="external">
          ethambutol
         </a>
         or
         <a class="drug drug_general" data-topicid="9864" href="/z/d/drug information/9864.html" rel="external">
          rifampin
         </a>
         . We continue treatment of
         <em>
          M. marinum
         </em>
         infection for one to two months following resolution of symptoms (total duration is typically three to four months). For disease involving the closed spaces of the hand or disease that responds poorly to drug therapy, surgical debridement may be warranted. (See
         <a class="local">
          'Mycobacterial infection'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Diaz JH, Lopez FA. Skin, soft tissue and systemic bacterial infections following aquatic injuries and exposures. Am J Med Sci 2015; 349:269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Diaz JH. Skin and soft tissue infections following marine injuries and exposures in travelers. J Travel Med 2014; 21:207.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bourque DL, Vinetz JM. Illnesses Associated with Freshwater Recreation During International Travel. Curr Infect Dis Rep 2018; 20:19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mekisic AP, Wardill JR. Crocodile attacks in the Northern Territory of Australia. Med J Aust 1992; 157:751.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flandry F, Lisecki EJ, Domingue GJ, et al. Initial antibiotic therapy for alligator bites: characterization of the oral flora of Alligator mississippiensis. South Med J 1989; 82:262.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pavia AT, Bryan JA, Maher KL, et al. Vibrio carchariae infection after a shark bite. Ann Intern Med 1989; 111:85.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Voss LM, Rhodes KH, Johnson KA. Musculoskeletal and soft tissue Aeromonas infection: an environmental disease. Mayo Clin Proc 1992; 67:422.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baddour LM. Extraintestinal Aeromonas infections--looking for Mr. Sandbar. Mayo Clin Proc 1992; 67:496.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tacket CO, Brenner F, Blake PA. Clinical features and an epidemiological study of Vibrio vulnificus infections. J Infect Dis 1984; 149:558.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levine WC, Griffin PM. Vibrio infections on the Gulf Coast: results of first year of regional surveillance. Gulf Coast Vibrio Working Group. J Infect Dis 1993; 167:479.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Czachor JS. Unusual aspects of bacterial water-borne illnesses. Am Fam Physician 1992; 46:797.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Janda JM, Abbott SL. Infections associated with the genus Edwardsiella: the role of Edwardsiella tarda in human disease. Clin Infect Dis 1993; 17:742.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hirai Y, Asahata-Tago S, Ainoda Y, et al. Edwardsiella tarda bacteremia. A rare but fatal water- and foodborne infection: Review of the literature and clinical cases from a single centre. Can J Infect Dis Med Microbiol 2015; 26:313.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chambers HF. Skin and Soft Tissue Infections in Persons Who Inject Drugs. Infect Dis Clin North Am 2021; 35:169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harris M, Scott J, Hope V, et al. Navigating environmental constraints to injection preparation: the use of saliva and other alternatives to sterile water among unstably housed PWID in London. Harm Reduct J 2020; 17:24.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baltes A, Akhtar W, Birstler J, et al. Predictors of skin and soft tissue infections among sample of rural residents who inject drugs. Harm Reduct J 2020; 17:96.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Srinivas J, Pillai M, Vinod V, Dinesh RK. Skin and Soft Tissue Infections due to Shewanella algae - An Emerging Pathogen. J Clin Diagn Res 2015; 9:DC16.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Veraldi S, Girgenti V, Dassoni F, Gianotti R. Erysipeloid: a review. Clin Exp Dermatol 2009; 34:859.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Limpert GH, Peacock JE Jr. Soft tissue infections due to noncholera vibrios. Am Fam Physician 1988; 37:193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gold WL, Salit IE. Aeromonas hydrophila infections of skin and soft tissue: report of 11 cases and review. Clin Infect Dis 1993; 16:69.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Doung-ngern P, Vatanaprasan T, Chungpaibulpatana J, et al. Infections and treatment of wounds in survivors of the 2004 Tsunami in Thailand. Int Wound J 2009; 6:347.
          </a>
         </li>
         <li class="breakAll">
          United States Centers for Disease Control and Prevention. Severe Vibrio vulnificus infections in the United States associated with warming coastal waters. Sept 1, 2023. https://emergency.cdc.gov/han/2023/han00497.asp?ACSTrackingID=USCDC_511-DM112179&amp;ACSTrackingLabel=HAN%20497%20-%20General%20Public&amp;deliveryName=USCDC_511-DM112179.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Edelstein H. Mycobacterium marinum skin infections. Report of 31 cases and review of the literature. Arch Intern Med 1994; 154:1359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sia TY, Taimur S, Blau DM, et al. Clinical and Pathological Evaluation of Mycobacterium marinum Group Skin Infections Associated With Fish Markets in New York City. Clin Infect Dis 2016; 62:590.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Noonburg GE. Management of extremity trauma and related infections occurring in the aquatic environment. J Am Acad Orthop Surg 2005; 13:243.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lewis FM, Marsh BJ, von Reyn CF. Fish tank exposure and cutaneous infections due to Mycobacterium marinum: tuberculin skin testing, treatment, and prevention. Clin Infect Dis 2003; 37:390.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aubry A, Mougari F, Reibel F, Cambau E. Mycobacterium marinum. Microbiol Spectr 2017; 5.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim R. Letter: Tetracycline therapy for atypical mycobacterial granuloma. Arch Dermatol 1974; 110:299.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Loria PR. Minocycline hydrochloride treatment for atypical acid-fast infection. Arch Dermatol 1976; 112:517.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Black MM, Eykyn SJ. The successful treatment of tropical fish tank granuloma (Mycobacterium marinum) with co-trimoxazole. Br J Dermatol 1977; 97:689.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175:367.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Collins CH, Grange JM, Noble WC, Yates MD. Mycobacterium marinum infections in man. J Hyg (Lond) 1985; 94:135.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chow SP, Ip FK, Lau JH, et al. Mycobacterium marinum infection of the hand and wrist. Results of conservative treatment in twenty-four cases. J Bone Joint Surg Am 1987; 69:1161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aubry A, Chosidow O, Caumes E, et al. Sixty-three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolates. Arch Intern Med 2002; 162:1746.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murphey DK, Septimus EJ, Waagner DC. Catfish-related injury and infection: report of two cases and review of the literature. Clin Infect Dis 1992; 14:689.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 7646 Version 26.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25374398" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Skin, soft tissue and systemic bacterial infections following aquatic injuries and exposures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24628985" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Skin and soft tissue infections following marine injuries and exposures in travelers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29789961" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Illnesses Associated with Freshwater Recreation During International Travel.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1453999" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Crocodile attacks in the Northern Territory of Australia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2783788" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Initial antibiotic therapy for alligator bites: characterization of the oral flora of Alligator mississippiensis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2660648" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Vibrio carchariae infection after a shark bite.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1405767" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Musculoskeletal and soft tissue Aeromonas infection: an environmental disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1405778" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Extraintestinal Aeromonas infections--looking for Mr. Sandbar.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6725989" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Clinical features and an epidemiological study of Vibrio vulnificus infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8421186" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Vibrio infections on the Gulf Coast: results of first year of regional surveillance. Gulf Coast Vibrio Working Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1514473" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Unusual aspects of bacterial water-borne illnesses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8268359" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Infections associated with the genus Edwardsiella: the role of Edwardsiella tarda in human disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26744588" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Edwardsiella tarda bacteremia. A rare but fatal water- and foodborne infection: Review of the literature and clinical cases from a single centre.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33303334" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Skin and Soft Tissue Infections in Persons Who Inject Drugs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32276626" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Navigating environmental constraints to injection preparation: the use of saliva and other alternatives to sterile water among unstably housed PWID in London.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33267848" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Predictors of skin and soft tissue infections among sample of rural residents who inject drugs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25859455" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Skin and Soft Tissue Infections due to Shewanella algae - An Emerging Pathogen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19663854" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Erysipeloid: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3278565" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Soft tissue infections due to noncholera vibrios.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8448321" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Aeromonas hydrophila infections of skin and soft tissue: report of 11 cases and review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19912391" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Infections and treatment of wounds in survivors of the 2004 Tsunami in Thailand.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19912391" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Infections and treatment of wounds in survivors of the 2004 Tsunami in Thailand.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8002687" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Mycobacterium marinum skin infections. Report of 31 cases and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26673347" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Clinical and Pathological Evaluation of Mycobacterium marinum Group Skin Infections Associated With Fish Markets in New York City.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16112981" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Management of extremity trauma and related infections occurring in the aquatic environment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12884164" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Fish tank exposure and cutaneous infections due to Mycobacterium marinum: tuberculin skin testing, treatment, and prevention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28387180" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Mycobacterium marinum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4852947" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Letter: Tetracycline therapy for atypical mycobacterial granuloma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1267459" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Minocycline hydrochloride treatment for atypical acid-fast infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/603751" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : The successful treatment of tropical fish tank granuloma (Mycobacterium marinum) with co-trimoxazole.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17277290" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3886781" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Mycobacterium marinum infections in man.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3667646" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Mycobacterium marinum infection of the hand and wrist. Results of conservative treatment in twenty-four cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12153378" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Sixty-three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1562661" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Catfish-related injury and infection: report of two cases and review of the literature.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
